Records containing: IgA Nephropathy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-01-25Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2016-12-05Multi-center, Randomized, Open Label, Comparative, Phase IV Study to Evaluate the Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid for 48 Weeks in Advanced IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2016-11-18A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2016-09-07Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers
-
CLINICAL_TRIALS study record update · 2016-08-22IgA Nephropathy, Lymphocyte Homing and IgA Class Switch
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-07-06Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy: a Multicentre, Double-blind, Double-dummy, Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2015-09-22Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2015-08-20Histological and Clinical Biomarkers to Predict the Progression of IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2015-08-19A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy: an Observational Study
-
CLINICAL_TRIALS study record update · 2015-08-03Paricalcitol for the Treatment of Immunoglobulin A Nephropathy - A Randomized Cross-Over Study
-
CLINICAL_TRIALS study record update · 2015-07-30A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2015-07-09Potential of Periostin as a Tissue and Urinary Biomarker in Lupus Nephritis and IgA Nephropathy Patients
-
CLINICAL_TRIALS study record update · 2015-07-03Aliskiren Combined With Losartan in Immunoglobulin A Nephropathy: an Open-label Pilot Study
-
CLINICAL_TRIALS study record update · 2015-04-02Prospective Clinical Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis.
-
CLINICAL_TRIALS study record update · 2014-10-01A Randomized Controlled Trial of Mycophenolate Mofetil in Patients With IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2014-08-21Double-blind, Randomized Placebo-controlled Clinical Trial for the Efficacy and Safety of a Calcineurin Inhibitor, Tacrolimus(Prograf Cap®) in Patients With Non-nephrotic Albuminuric, Normotensive IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2014-07-11Phase 3 Study of Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f
-
CLINICAL_TRIALS study record update · 2014-05-15Aldosterone Breakthrough During Diovan (Valsartan), Tekturna (Aliskiren), and Combination (Valsartan+Aliskiren) Anti-hypertensive Therapy in Patients With Proteinuric Kidney Disease
-
CLINICAL_TRIALS study record update · 2013-08-28An Observational Study of the Relationship Between Pathological Variants and Clinical Data at Presentation and Follow-up in IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2013-06-17Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath
-
CLINICAL_TRIALS study record update · 2013-01-31Proof-of-concept Study of Efficacy and Safety of Dietary Supplementation With Probiotics in IgAN Patients
-
CLINICAL_TRIALS study record update · 2012-12-04The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy - A Randomized Cross-Over Study
-
CLINICAL_TRIALS study record update · 2012-09-27Minimization, Double-blind, Placebo-controlled, Multi-center, Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2012-07-10The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2011-07-13Steroids and Azathioprine in Early and Advanced IgA Nephropathy: Amendments to a Prospective Randomised Multicenter Trial